期刊文献+

抑制膜联蛋白A2表达对人胃癌细胞株裸鼠移植瘤生长的影响及机制 被引量:2

Effect of ANXA2 on Growth of Implanted Human Gastric Cancer in Nude Mice
原文传递
导出
摘要 [目的]通过体内研究探讨膜联蛋白A2(ANXA2)对胃癌生长的影响及相关作用机制。[方法]常规培养人胃癌细胞株BGC-823;将细胞接种到裸鼠皮下制备移植瘤模型。制模成功后随机分组,分别以脂质体/ANXA2-siRNA复合物(实验组)、脂质体/Non-siRNA复合物(对照组)或生理盐水(空白组)分别在各组肿瘤局部注射,每4d干预1次。干预4次后处死,绘制肿瘤生长曲线并比较瘤重。应用荧光定量RT-PCR及免疫组化技术检测各组ANXA2、增殖细胞核抗原(PCNA)、p27m RNA和蛋白表达。[结果]裸鼠皮下移植瘤造模成功率100.00%(15/15)。实验组肿瘤生长比其他两组缓慢,最终体积实验组为(1680.26±110.51)mm3,对照组为(2194.18±188.48)mm3,空白组(2172.37±212.36)mm3(F=9.341,P=0.004);肿瘤重量实验组(20.63±0.46)g,对照组为(22.92±0.86)g,空白组为(23.44±0.90)g(F=11.688,P=0.002)。PCR及免疫组化结果显示实验组ANXA2、PCNAm RNA和蛋白表达明显低于其他两组(P<0.05),而p27m RNA和蛋白表达明显高于其他两组(P<0.01)。[结论 ]抑制ANXA2基因表达后胃癌移植瘤的生长明显受到抑制,这可能与ANXA2基因调控PCNA、p27表达有关。 [Objective] To investigate the effect of Annexin A2(ANXA2) on the growth of gastric cancer in vivo. [Methods] Human gastric cancer BGC-823 cells were inoculated into 15 nude mice subcutaneously to establish gastric cancer model. The cancer-bearing nude mice were divided into 3 groups randomly with 5 in each group,the animals were treated with liposome/ANXA2-siRNA compound(ANXA2 group),liposome/non-siRNA compound(control group) or normal saline(blank group),respectively. After nude mice were sacrificed,volume and weight of tumors were measured,and the expressions of ANXA2,PCNA,p27 m RNA and protein were detected with fluorescence quantitative RT-PCR and immunohistochemistry,respectively. [Results] The tumor growth in ANXA2 group was slower than that in other 2 groups; and the final volume of tumors was(1680.26±110.51)mm3in ANXA2 group,(2194.18±188.48)mm3in control group and(2172.37±212.36)mm3in blank group(F =9.341,P =0.004). The weight of tumors was(20.63 ±0.46)g in ANXA2 group,(22.92±0.86)g in control group and(23.44 ±0.90)g in blank group(F=11.688,P=0.002). The expressions of ANXA2 and PCNA m RNA and protein in ANXA2 group were lower than those in other 2 groups,whereas expressions of p27 m RNA and protein in ANXA2 group were higher than those in the other 2 groups(P〈0.01). [Conclusion] The growth of tumor can be inhibited after ANXA2 inhibition,indicating that ANXA2 may regulate expressions of PCNA and p27 in gastric cancer.
出处 《肿瘤学杂志》 CAS 2016年第9期693-697,共5页 Journal of Chinese Oncology
关键词 胃肿瘤 膜联蛋白A2 肿瘤生长 裸鼠 gastric neoplasms Annexin A2 tumor growth nude mice
  • 相关文献

参考文献3

二级参考文献43

  • 1于宝华,周晓燕.PI3K/Akt/mTOR的信号传导通路在恶性肿瘤中的研究进展[J].中华病理学杂志,2005,34(10):674-676. 被引量:20
  • 2Mendelsohn J,Baselga J.The EGF receptor family as targets for cancer therapy[J].Oncogene,2000,19(56):6550-6565.
  • 3Balak MN,Gong Y,Riely GJ,et al.Novel D761Y and common secondary T790M mutations in epidermal growth factor receptormutant lung adenocarcinomas with acquired resistance to kinase inhibitors[J].Clin Cancer Res,2006,12(21):6494-6501.
  • 4Kobayashi S,Boggon TJ,Dayaram T,et al.EGFR mutation and resistance of non-small-cell lung cancer to gefitinib[J].N Engl J Med,2005,352(8):786-792.
  • 5Kosaka T,Yatabe Y,Endoh H,et al.Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib[J].Clin Cancer Res,2006,12(19):5764-5769.
  • 6Kwak EL,Sordella R,Bell DW,et al.Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib[J].Proc Natl Acad Sci U S A,2005,102(21):7665-7670.
  • 7Pao W,Miller VA,Politi KA,et al.Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain[J].PLoS Med,2005,2(3):e73.
  • 8Bean J,Riely GJ,Balak M,et al.Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma[J].Clin Cancer Res,2008,14 (22):7519-7525.
  • 9Traxler P,Bold G,Buchdunger E,et al.Tyrosine kinase inhibitors:from rational design to clinical trials[J].Med Res Rev,2001,21(16):499-512.
  • 10Barker AJ,Gibson KH,Grundy W,et al.Studies leading to the identification of ZD1839 (IRESSA):an orally active,selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer[J].Bioorg Med Chem Lett,2001,11(14):1911-1914.

共引文献16

同被引文献25

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部